Medtronic plc (MDT) Yield on Cost (YOC): 3.46%
The yield on cost (YOC) for Medtronic plc (MDT) is 3.46%.
MDT Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
3.46%
Forward Yield on Cost Projections
If you buy MDT today at the current stock price of $81.98 with a yield of 3.46% and dividends continue to grow at the historical rate (4.4% CAGR), your YOC would be:
Current Yield
3.46%
YOC in 3 Years
3.97%
YOC in 5 Years
4.35%
YOC in 10 Years
5.45%
Interactive Yield on Cost Calculator
Project custom investment returns for Medtronic plc (MDT) based on your custom cost basis.
Starting Yield
3.46%
Ending YOC
6.63%
Year 15 Dividend
$5.43
Cum. Dividends Recd.
$61.27
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $2.84 | — | 3.46% | $0.00 |
| Year 1 | $2.97 | +4.42% | 3.62% | $2.97 |
| Year 2 | $3.10 | +4.42% | 3.78% | $6.06 |
| Year 3 | $3.23 | +4.42% | 3.94% | $9.30 |
| Year 4 | $3.38 | +4.42% | 4.12% | $12.67 |
| Year 5 | $3.53 | +4.42% | 4.30% | $16.20 |
| Year 6 | $3.68 | +4.42% | 4.49% | $19.88 |
| Year 7 | $3.84 | +4.42% | 4.69% | $23.72 |
| Year 8 | $4.01 | +4.42% | 4.90% | $27.74 |
| Year 9 | $4.19 | +4.42% | 5.11% | $31.93 |
| Year 10 | $4.38 | +4.42% | 5.34% | $36.31 |
| Year 11 | $4.57 | +4.42% | 5.57% | $40.88 |
| Year 12 | $4.77 | +4.42% | 5.82% | $45.65 |
| Year 13 | $4.98 | +4.42% | 6.08% | $50.63 |
| Year 14 | $5.20 | +4.42% | 6.35% | $55.83 |
| Year 15 | $5.43 | +4.42% | 6.63% | $61.27 |
Yield on Cost (YOC) Formula
Formula: Yield on Cost = Annual Dividend / Original Purchase Price × 100
Inputs shown in the projection:
- Original purchase price.
- Annual dividend per share at the starting point.
- Assumed annual dividend growth rate.
- Projected annual dividend divided by original purchase price.
Note: Forward projections assume dividends continue to grow at the designated growth rate. Actual dividend payments are declared by corporate boards and are subject to change.
Medtronic plc Yield on Cost (YOC) Formula & Definition
Yield on Cost shows the dividend yield based on your original purchase price. As dividends grow, your YOC increases even if the market yield stays the same.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medtronic plc Yield on Cost (YOC) FAQ
- What is the yield on cost (YOC) for Medtronic plc (MDT)?
- The yield on cost (YOC) for MDT stock is 3.46%.
About Medtronic plc
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Geoffrey Straub Martha